Social distancing to avoid SARS-Cov-2 infection in cancer and non-cancer patients.

Authors

Goetz Kloecker

Goetz H. Kloecker

St Elizabeth Healthcare, Edgewood, KY

Goetz H. Kloecker , Jason Ellis , Leslie Korbee , Joseph Nolan , Royce Calhoun , Barbara Logan , Daniel Blake Flora , Douglas B. Flora , Philp Hartman

Organizations

St Elizabeth Healthcare, Edgewood, KY, Saint Elizabeth Healthcare Edgewood, Edgewood, KY, Northern Kentucky University, Highland Heights, KY, Univ Hosp/Univ of Cincinnati, Cincinnati, OH, OHC Inc, Crestview Hills, KY

Research Funding

No funding received
None

Background: Social distancing has been recommended by the CDC to avoid exposure to SARS-CoV-2. Cancer patients on or after active therapy appear to be more prone to COVID being symptomatic and life threatening. When evaluating cancer patients’ risk of acquiring COVID it is essential to know the behavior of cancer patients that will affect their risk of exposure. However, it is not known to what degree social distancing is practiced by cancer patients compared to non-cancer patients and what factors lead to the decision to distance oneself. Methods: After a pilot phase using patients MyChart messaging, links to the electronic questionnaires were texted to patients using Twillio. Responses were stored on REDCap. Six questions about their social distancing behavior and mask wearing were posed and responses were compared between cancer and non-cancer patients. Demographics, comorbidities and a questionnaire about anxiety (GAD-7 scale for Generalized Anxiety Disorder) were recorded. To assess differences between cancer and non-cancer groups Bonferroni-corrected chi-square tests and proportions confidence intervals were used. Results: The pilot survey was sent in mid-2020 and the full survey followed in January 2021 during a high community COVID incidence. 387 cancer patients (32.4% responded and 503 non-cancer (22.9% responded) patients completed the survey. Questions about leaving their house, driving, shopping, friends and family indicated that patients with cancer are more cautious (p < 0.001). Cancer patients were up to 20% more likely to distance themselves. No evidence of a difference was seen in wearing a mask, at least 85 % most of the time. A majority of respondents were female (63% vs 71%). Cancer patients were older ( > 60 years, 69 % vs 45%) and less likely to work (52% vs 31%) or less likely to be white collar workers (21% vs 38%). There was no difference of the anxiety score in both groups (not at all anxious, 54%). Conclusions: Cancer patients’ responses revealed a distancing behavior that would likely lower the risk exposure to SARS-CoV-2. It is unclear, which of the demographic differences would account for this behavior, although remarkably anxiety was not a clear motivating factor. The high acceptance of masks is encouraging. Early publications during the pandemic and patient education suggesting a higher COVID risk for cancer patients may have reduced risk prone behavior. Considering COVID’s impact on the vulnerable cancer population and uncertainty in immunosuppressed patients about clearing the virus or adequately responding to a vaccine, further studies about health behavior and health promotion during the pandemic are needed.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Real-World Data/Outcomes

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr e18697)

DOI

10.1200/JCO.2021.39.15_suppl.e18697

Abstract #

e18697

Abstract Disclosures

Similar Abstracts

First Author: Jenny Yang

First Author: Edison Tsui

Abstract

2023 ASCO Genitourinary Cancers Symposium

COVID-19 vaccination behavior and outcomes in patients with genitourinary cancer in comparison with other cancer types.

First Author: Hyma Vani Polimera